{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:09:25Z","timestamp":1764601765327,"version":"build-2065373602"},"reference-count":64,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Daptomycin is a cyclic lipopeptide antibiotic with bactericidal effects against multidrug-resistant Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE). For critically ill patients, especially in the presence of implants, daptomycin is an important therapeutic option. Left ventricle assist devices (LVADs) can be utilized for intensive care patients with end-stage heart failure as a bridge to transplant. We conducted a single-center prospective trial with critically ill adults with LVAD who received prophylactic anti-infective therapy with daptomycin. Our study aimed to evaluate the pharmacokinetics of daptomycin in the blood serum and wound fluids after LVAD implantation. Daptomycin concentration were assessed over three days using high-performance liquid chromatography (HPLC). We detected a high correlation between blood serum and wound fluid daptomycin concentration at 12 h (IC95%: 0.64 to 0.95; r = 0.86; p &lt; 0.001) and 24 h (IC95%: \u22120.38 to 0.92; r = 0.76; p &lt; 0.001) after antibiotic administration. Our pilot clinical study provides new insights into the pharmacokinetics of daptomycin from the blood into wound fluids of critically ill patients with LVADs.<\/jats:p>","DOI":"10.3390\/antibiotics12050904","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T02:56:57Z","timestamp":1684119417000},"page":"904","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Daptomycin Pharmacokinetics in Blood and Wound Fluid in Critical Ill Patients with Left Ventricle Assist Devices"],"prefix":"10.3390","volume":"12","author":[{"given":"Stefanie","family":"Calov","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital T\u00fcbingen, Eberhard Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Munzel","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, BG Trauma Center, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anka C.","family":"Roehr","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, General Hospital of Heidenheim, 89522 Heidenheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9482-5094","authenticated-orcid":false,"given":"Otto","family":"Frey","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, General Hospital of Heidenheim, 89522 Heidenheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5182-8295","authenticated-orcid":false,"given":"Lina Maria Serna","family":"Higuita","sequence":"additional","affiliation":[{"name":"Department for Translational Bioinformatics and Medical Data Integration Center, Eberhard Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Wied","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital T\u00fcbingen, Eberhard Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rosenberger","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital T\u00fcbingen, Eberhard Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene A.","family":"Haeberle","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital T\u00fcbingen, Eberhard Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-0691","authenticated-orcid":false,"given":"Kristian-Christos","family":"Ngamsri","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital T\u00fcbingen, Eberhard Karls University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,13]]},"reference":[{"key":"ref_1","first-page":"76","article-title":"Antimicrobial prophylaxis in minor and major surgery","volume":"81","author":"Bassetti","year":"2015","journal-title":"Minerva Anestesiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: A Position Paper","volume":"46","author":"Alffenaar","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41579-021-00578-9","article-title":"Optimizing antimicrobial use: Challenges, advances and opportunities","volume":"19","author":"Rawson","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41564-019-0503-9","article-title":"Defining and combating antibiotic resistance from One Health and Global Health perspectives","volume":"4","author":"Coque","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcrc.2020.08.027","article-title":"The ONTAI study\u2014A survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units","volume":"60","author":"Liebchen","year":"2020","journal-title":"J. Crit. Care"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10096-019-03769-8","article-title":"Diagnostic and medical needs for therapeutic drug monitoring of antibiotics","volume":"39","author":"Mabilat","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.21037\/jtd.2020.03.26","article-title":"Left ventricular assist device-associated infections: Incidence and risk factors","volume":"12","author":"Rahal","year":"2020","journal-title":"J. Thorac. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/03913988221082690","article-title":"Derivation and validation of the bridge to transplantation with left ventricular assist device score for 1 year mortality after heart transplantation. The BTT-LVAD score","volume":"45","author":"Okoh","year":"2022","journal-title":"Int. J. Artif. Organs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10047-021-01289-x","article-title":"A pilot clinical trial of a self-management intervention in patients with a left ventricular assist device","volume":"25","author":"Casida","year":"2022","journal-title":"J. Artif. Organs"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.healun.2020.03.002","article-title":"Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial","volume":"39","author":"Patel","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e13692","DOI":"10.1111\/ctr.13692","article-title":"Outcomes of patients with infection related to a ventricular assist device after heart transplantation","volume":"33","author":"Moayedi","year":"2019","journal-title":"Clin. Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cmi.2017.03.008","article-title":"Left ventricular assist device-related infections: A multicentric study","volume":"23","author":"Revest","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.healun.2017.06.007","article-title":"An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection","volume":"36","author":"Kusne","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13019-021-01589-6","article-title":"Prevalence and management of driveline infections in mechanical circulatory support\u2014A single center analysis","volume":"16","author":"Juraszek","year":"2021","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00003495-200464040-00009","article-title":"Daptomycin","volume":"64","author":"Fenton","year":"2004","journal-title":"Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1021\/acs.jmedchem.0c00780","article-title":"Structure\u2013Activity Relationships of Daptomycin Lipopeptides","volume":"63","author":"Karas","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Chuang, Y.C., Wang, J.T., Lin, H.Y., and Chang, S.C. (2014). Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: Systematic review and meta-analysis. BMC Infect. Dis., 14.","DOI":"10.1186\/s12879-014-0687-9"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14656566.2018.1442826","article-title":"Current and future treatment options for community-associated MRSA infection","volume":"19","author":"Khan","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1749-8090-9-63","article-title":"Eradication of a chronic wound and driveline infection after redo-LVAD implantation","volume":"9","author":"Walter","year":"2014","journal-title":"J. Cardiothorac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1111\/j.1399-3062.2012.00775.x","article-title":"Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: Case report and review of the literature","volume":"14","author":"Levy","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/apm.12951","article-title":"Antibiotic therapy as personalized medicine\u2014General considerations and complicating factors","volume":"127","author":"Moser","year":"2019","journal-title":"Apmis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ajhp\/zxaa128","article-title":"Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and beta-lactam antibiotics to maximize effectiveness and minimize toxicity","volume":"77","author":"Cusumano","year":"2020","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2014.05.007","article-title":"The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients","volume":"77","author":"Hites","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijantimicag.2018.09.015","article-title":"Current use of daptomycin and systematic therapeutic drug monitoring: Clinical experience in a tertiary care institution","volume":"53","author":"Galar","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1248\/bpb.b22-00276","article-title":"Target Therapeutic Ranges of Anti-MRSA Drugs, Linezolid, Tedizolid and Daptomycin, and the Necessity of TDM","volume":"45","author":"Matsumoto","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/aor.14254","article-title":"Sequential organ failure assessment score improves survival prediction for left ventricular assist device recipients in intensive care","volume":"46","author":"Chatterjee","year":"2022","journal-title":"Artif. Organs"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s40265-016-0610-3","article-title":"Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients","volume":"76","author":"Pensi","year":"2016","journal-title":"Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ejhf.779","article-title":"Left ventricular assist device therapy in advanced heart failure: Patient selection and outcomes","volume":"19","author":"Gustafsson","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hfc.2021.05.007","article-title":"Left Ventricular Assist Device: Indication, Timing, and Management","volume":"17","author":"Frigerio","year":"2021","journal-title":"Heart Fail. Clin."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MAT.0000000000000684","article-title":"Left Ventricular Assist Device Infections: A Systematic Review","volume":"64","author":"Stulak","year":"2018","journal-title":"ASAIO J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.athoracsur.2017.07.050","article-title":"Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients","volume":"105","author":"Papathanasiou","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10047-018-1078-6","article-title":"Left ventricular assist device-related infections: Does the time of onset matter?","volume":"22","author":"Lehnert","year":"2019","journal-title":"J. Artif. Organs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/cid\/cit536","article-title":"Clinical Manifestations and Management of Left Ventricular Assist Device-Associated Infections","volume":"57","author":"Nienaber","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e13686","DOI":"10.1111\/tid.13686","article-title":"The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: A retrospective cohort from a tertiary care center","volume":"23","author":"Hamad","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/aor.14477","article-title":"Ten-year retrospective cohort analysis of ventricular assist device infections","volume":"47","author":"Spano","year":"2022","journal-title":"Artif. Organs"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins","volume":"194","author":"Pogliano","year":"2012","journal-title":"J. Bacteriol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Howden, B.P., McEvoy, C.R.E., Allen, D.L., Chua, K., Gao, W., Harrison, P.F., Bell, J., Coombs, G., Bennett-Wood, V., and Porter, J.L. (2011). Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002359"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMoa1011138","article-title":"Genetic Basis for In Vivo Daptomycin Resistance in Enterococci","volume":"365","author":"Arias","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Peleg, A.Y., Miyakis, S., Ward, D.V., Earl, A.M., Rubio, A., Cameron, D.R., Pillai, S., Moellering, R.C., and Eliopoulos, G.M. (2012). Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0028316"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.00247-06","article-title":"Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers","volume":"50","author":"Benvenuto","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1469-0691.2006.01342.x","article-title":"The efficacy and safety of daptomycin: First in a new class of antibiotics for Gram-positive bacteria","volume":"12","author":"Rybak","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.48.8.2799-2807.2004","article-title":"Population Pharmacokinetics of Daptomycin","volume":"48","author":"Dvorchik","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1586\/eri.13.3","article-title":"Current use of daptomycin in cardiac surgery and postoperative intensive care","volume":"11","author":"Kanzler","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jbcr\/iraa020","article-title":"Efficacy and Safety of High Vs Standard Daptomycin Doses Examined in Chinese Patients With Severe Burn Injuries by Pharmacokinetic Evaluation","volume":"41","author":"Huang","year":"2020","journal-title":"J. Burn. Care Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/bcp.13131","article-title":"Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy","volume":"83","author":"Xu","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jac\/dkp155","article-title":"Comparison of the pharmacokinetics, safety and tolerability of daptomycin in healthy adult volunteers following intravenous administration by 30 min infusion or 2 min injection","volume":"64","author":"Chakraborty","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1128\/AAC.46.1.31-33.2002","article-title":"Pharmacokinetics and Inflammatory Fluid Penetration of Intravenous Daptomycin in Volunteers","volume":"46","author":"Wise","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/AAC.00589-08","article-title":"In Vivo Microdialysis Study of the Penetration of Daptomycin into Soft Tissues in Diabetic versus Healthy Volunteers","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/jac\/dkq109","article-title":"Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections","volume":"65","author":"Schintler","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jocs.16075","article-title":"A persistent problem\u2014The dreaded LVAD driveline infection","volume":"37","author":"Copeland","year":"2021","journal-title":"J. Card. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jocs.16073","article-title":"Association between continuous-flow left ventricular assist device infections requiring long-term antibiotic use and post-heart transplant morbidity and mortality","volume":"37","author":"Lambadaris","year":"2021","journal-title":"J. Card. Surg."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jgar.2021.04.020","article-title":"In vitro activity of ceftaroline and comparators against bacterial isolates collected globally from patients with skin infections","volume":"26","author":"Stone","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_56","first-page":"1240","article-title":"Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute","volume":"70","author":"Satlin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1592\/phco.31.6.527","article-title":"High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jac\/dkv368","article-title":"When sepsis persists: A review of MRSA bacteraemia salvage therapy","volume":"71","author":"Kullar","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/652767","article-title":"Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis","volume":"50","author":"Bhavnani","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1111\/jocs.15010","article-title":"Analysis of clinical outcome and postoperative organ function effects in a propensity-matched comparison between conventional and minimally invasive mitral valve surgery","volume":"35","author":"Missault","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/FTD.0000000000000940","article-title":"Therapeutic Drug Monitoring of Antibiotics: Defining the Therapeutic Range","volume":"44","author":"Brady","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fpsyg.2017.00456","article-title":"Repeated Measures Correlation","volume":"8","author":"Bakdash","year":"2017","journal-title":"Front. Psychol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e0015221","DOI":"10.1128\/mSystems.00152-21","article-title":"Differential Analysis of Longitudinal Methicillin-Resistant Staphylococcus aureus Colonization in Relation to Microbial Shifts in the Nasal Microbiome of Neonatal Piglets","volume":"6","author":"Patel","year":"2021","journal-title":"Msystems"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijid.2017.01.017","article-title":"Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures","volume":"57","author":"Ogami","year":"2017","journal-title":"Int. J. Infect. Dis."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/5\/904\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:34:18Z","timestamp":1760124858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/12\/5\/904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["antibiotics12050904"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics12050904","relation":{},"ISSN":["2079-6382"],"issn-type":[{"type":"electronic","value":"2079-6382"}],"subject":[],"published":{"date-parts":[[2023,5,13]]}}}